WEE1 and neoplasm: Given the pivotal role of Wee1 in the S-G2 checkpoint, the inhibition of Wee1 kinase is expected to exert an anti-tumor effect by abrogating the G2 checkpoint, specifically in p53 negative tumors in combination with DNA damaging drugs.